![]() Arena Pharma: Weight-Loss Drug Approved! Adam Feuerstein Jun 27, 2012 2:56 PM EDT Updated with new information throughout. FDA Approves New Weight-Loss Drug Saxenda cleared for use by adults who are obese or overweight and have at least one weight-related condition Please note: This article was published more than one year ago. The facts and conclusions presented may have. The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. The FDA has approved three weight loss pills in recent years. It cleared Vivus Inc. The first new prescription diet drug in 13 years won Food and Drug Administration (FDA) approval on Wednesday, offering a new alternative to aid weight loss for the nearly one in three Americans who are considered obese. The new drug, called Belviq (lorcaserin), is. The FDA cleared use of the company's Stratus sinus device with saline solution, but a Department of Justice statement said the company never intended to use it this way. Instead, the company designed Stratus to be used with corticosteroids. FDA-Approved Weight Loss Drugs: Can They Help You? Cimetidine Hydrochloride Cimetidine contains an imidazole ring, and is chemically related to histamine. Cimetidine hydrochloride has a bitter taste and characteristic odor. 12/23/14 - FDA clears Novo Nordisk's weight loss drug Saxenda NEW YORK (AP) The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss. FDA approves lorcaserin, first weight- loss drug since 1. Nor, the FDA said, has the effect of Belviq on the long- term risk of having, or dying from, a heart attack or stroke. The approval comes after a lengthy review by an agency under pressure to help Americans lose weight but also to screen out drugs that could prove dangerous once embraced by a large number of patients. Just over 1 in 3 adult Americans is considered obese, and an additional 3. Type 2 diabetes, heart disease and certain cancers linked to obesity will overwhelm the U. S. Already, obesity- related disease is estimated to account for $1. ![]() The Food and Drug Administration cleared the Maestro Rechargeable System, the first weight-loss device that targets the pathway between the brain and the stomach that controls feelings of hunger and fullness.A marijuana drug test is easy to use and 98% accurate. An inexpensive way to determine recent marijuana use by testing for THC in urine. Accurate Tests.since 1996. ![]() Belviq, made by San Diego- based Arena Pharmaceuticals, is one of four weight- loss drugs the FDA has anguished over in recent years. Safety concerns have prompted the agency to order the makers of two other candidate drugs to conduct and comb through additional research. A third drug was withdrawn after it was linked to an elevated suicide risk. In the 2. 8 months since the makers of Belviq submitted the drug for FDA consideration, the agency also demanded the withdrawal of Meridia after studies showed it increased the risk of heart attack and stroke. That left only two FDA- approved weight- loss drugs on the market: orlistat and phentermine. The result has been — to the growing frustration of many obesity experts — almost no pharmaceutical aid for a steadily growing population of Americans desperate for help in shedding pounds. Belviq offers would- be dieters modest benefits. One clinical trial found that two- thirds of patients on the drug lost 5% of their body weight, while one- third lost at least 1. Subjects' average weight loss was 1. Still, even this kind of modest weight loss can help lower a patient's blood pressure, improve blood cholesterol measures and hold off or delay the onset of Type 2 diabetes, experts said. As a means of boosting weight loss results without surgery, lorcaserin . Sharma, an obesity expert and professor of medicine at the University of Alberta in Canada. The FDA's decision came after the makers of lorcaserin allayed fears, raised in clinical trials, that the drug might damage heart valves. Experts were also worried that animals given a higher dose than the amount intended for patients had an increased incidence of brain and breast tumors. By last May, Arena and its partner, Tokyo- based Eisai Pharmaceuticals, brought the FDA data showing that such worrisome side effects were highly unlikely to emerge at the doses it expected patients would be prescribed. On Wednesday, Arena said it would conduct further studies to assess the safety and effectiveness of Belviq's long- term use and its safety for weight management in children. The drug is not FDA- approved for children, but doctors may legally prescribe it to them off- label. Still to come are FDA decisions on two other weight- loss drug candidates. Qnexa, a combination of the diet drug phentermine and the anticonvulsant topiramate, sponsored by. Vivus Inc. Lee Kaplan, head of Massachusetts General Hospital's weight management program, said that while lorcaserin's effects appeared modest, there were some patients who could be expected to respond to the drug with major weight loss. Lorcaserin . But it offers a very important tool.. It's a tool I know I'll use. Jack Der- Sarkissian said the new pill .
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |